Related Experiment Video
Updated: Jan 20, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Prevalence of macrolide resistance in Mycoplasma pneumoniae in The Netherlands
Patrick D J Sturm1, Julius M Van Niekerk1, Pieter P A Lestrade2
1Department of Medical Microbiology, Laurentius Hospital, Roermond, The Netherlands.
Background:
Macrolide resistance in Mycoplasma pneumoniae is an increasing concern worldwide.
Objectives:
To investigate the prevalence of macrolide resistance in M. pneumoniae in The Netherlands.
Methods:
All non-duplicate consecutive specimens with a positive M. pneumoniae PCR were prospectively collected by four hospital laboratories during the outbreak of M. pneumoniae infection in 2023/2024 in The Netherlands. The two most common mutations in the 23S rRNA gene that are known to cause macrolide resistance, A2063G and A2064G, were detected by PCR with melting curve analysis.
Results:
PCR-positive specimens were identified in 268 patients. Of the 268 PCR-positive specimens, 238 were available for analysis of which 235 could be amplified for mutational analysis. Mutations were detected in 7 of 235 specimens (3%).
Conclusions:
The low resistance rate of 3% still supports the use of macrolides for empirical treatment of M. pneumoniae infections in The Netherlands, but macrolide non-responsive infections should lead to the suspicion of resistant M. pneumoniae. Regular surveillance studies are important as clonal spread may cause rapid changes in resistance rates.
Related Concept Videos
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:01Optimized PCR-based Detection of Mycoplasma
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
13:27Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

